SEC Form 4 · accession 0001209191-18-064182
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Roberts
Officer — President and Director · Director
Period of report
Dec 22, 2018
Accepted (ET)
Dec 27, 2018 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 22, 2018 | M | 10 | — | A | 36,372 | D | |
| Common StockF2 | Dec 22, 2018 | F | 121 | $22.28 | D | 36,251 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Equivalent RightsF3 | — | Dec 22, 2018 | M | 10 | D | — | — | Common Stock | 10 | 5 | D |
Explanation of responses
- F1Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
- F2These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
- F3These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/22/2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.